Category: Today’s Highlights
Vertex Has Good News and Exelixis Is Reinforcing Its Outperformance
Read More
May 2, 2019
0
A Firm That Defied the Fierce Unwarranted Bear Market Day
Read More
May 7, 2019
0
Exelixis' and Daiichi Sankyo's Novel Antihypertensive Drug Minnebro® Hits the Japanese Market
Read More
May 13, 2019
0
Regeneron: Why the FDA Approval of EYLEA for Diabetic Retinopathy is Extremely Important.
Read More
May 14, 2019
0
Another Late-Stage Firm with Impressive Technology and Promising Products
Read More
May 16, 2019
0
The Medicines Company: Are Inclisiran's Clinical Trial Results Impressive?
Read More
May 21, 2019
0
Array BioPharma: Great News and a Learning Experience
Read More
May 21, 2019
0
Amgen Is Proving It Is Still the Biotech King. Nektar Forms a Subsidiary Firm to Market Its Pain Product NKTR-181, When Approved
Read More
May 24, 2019
0
IVERIC bio Stock Doubled and Continues to Outperform
Read More
November 1, 2019
0
Recent News from Incyte, Merck and Nektar
Read More
May 29, 2019
0
Search ProhostBiotech
Popular Links
23andMe Holding Co (ME)Abbott Laboratories (ABT)AbbVie Inc (ABBV)AbCelleraAbeona Therapeutics (ABEO)Ablynx (ABLX)AbVitro IncAcadia (ACAD)Acceleron Pharma (XLRN)AcelRx Pharmaceuticals (ACRX).Acorda Therapeutics Inc (ACOR)Acumen Pharmaceuticals (ABOS)AdaptImmune Therapeutics (ADAP)Adaptive BiotechnologiesADC Therapeutics (ADCT)Adimab LLCAdvanced Micro Devices (AMD)Advaxis (ADXS)Adverum Biotechnologies (ADVM)Aerie Pharmaceuticals (AERI)AgenTus TherapeuticsAgenus (AGEN)AgeX Therapeutics (AGE)Agilent Technologies (A)Agilis Biotherapeutics IncAgios Pharmaceuticals (AGIO)AIM ImmunoTech (AIM)Aimmune Therapeutics (AIMT)Akari Therapeutics (AKTX)Akashi TherapeuticsAkcea Therapeutics (AKCA)Akebia Therapeutics Inc (AKBA)Akero Therapeutics (AKRO)Akous Inc (a wholly owned subsidiary of Eli Lilly Company)Alder BioPharmaceuticals (ALDR)Alexion Pharmaceuticals (ALXN)Alkermes (ALKS)Allergan Plc (AGN)Allogene TherapeuticsAllogene Therapeutics (ALLO)